The QualityStocks Daily Monday, November 4th, 2019

Today's Top 3 Investment Newsletters

NetworkNewsWire (OCLND) +75.00%

SmallCapRelations (NTRR) +71.43%

QualityStocks (BNKPF) +51.35%

The QualityStocks Daily Stock List

AeroGrow International, Inc. (AERO)

Zacks, Awesome Penny Stocks, New Cannabis Ventures, TMXmoney, Daily Marijuana Observer, Market Screener, Stockhouse, Stockwatch, Last10k, Investing Daily, Stockopedia, Wallet Investor, and GlobeNewswire reported earlier on AeroGrow International, Inc. (AERO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

AeroGrow International, Inc. engages in the development, marketing, direct-selling, and wholesale of indoor garden systems to consumers and retailers internationally. The Company is the manufacturer and distributor of AeroGardens – the world’s foremost family of In-Home Garden Systems™. AeroGrow International, Inc. is a subsidiary of SMG Growing Media, Inc. Established in 2002, AeroGrow International is based in Boulder, Colorado. The Company’s shares trade on the OTC Markets Group’s OTCQB.

In 2013, AeroGrow International entered into a strategic partnership with Scotts Miracle-Gro to continue to expand the indoor gardening market. The Company’s AeroGardens allow anyone to grow farmer’s market fresh herbs, salad greens, tomatoes, chili peppers, flowers and more, indoors, simply and easily. AeroGrow’s primary products include indoor gardens and proprietary seed pod kits.

AeroGrow also provides grow lights and a patented nutrient formula. In addition, the Company provides various cooking, gardening, and decor accessories. It offers its in-home garden systems under the AeroGardens name. AeroGrow International’s products are used in the gardening, cooking, healthy eating, as well as home and office décor markets.

With the AeroGarden, plants grow in water five times faster than in soil. No herbicides or pesticides are part of the process, and AeroGarden grows non-GMO (Genetically Modified Organism) seeds. Customers can grow plants year round.

This past August, AeroGrow International announced results for its Q1 ended June 30, 2019. It recorded Net Revenue of $4.5 million. This represents an increase of 20 percent over the same period in the previous year. Loss from operations was $1,053K, up from $654K in the previous year period.

AeroGrow International President & Chief Executive Officer, Mr. J. Michael Wolfe, said, “I am very pleased with our continued strong sales growth for the 1st Quarter of our Fiscal Year 2020. With sales up 20%, we continued the strong momentum we’ve had recently and realized particularly good results on our e-commerce platforms (Amazon, AeroGarden.com and several other on-line retailers, notably Macy’s and Kohl’s).”

AeroGrow International, Inc. (AERO), closed Monday's trading session at $0.90, even for the day, on 4,976 volume with 15 trades. The average volume for the last 3 months is 7,598 and the stock's 52-week low/high is $0.740000009/$2.75.

chart

Cresco Labs, Inc. (CRLBF)

New Cannabis Ventures, Stockhouse, CannabisMarketCap, Pot Stock News, Profit Confidential, Technical420, Green Market Report, TMXmoney, Midas Letter, TipRanks, NIC Investors, Equities, Investopedia, Market Screener, Wallet Investor, Stockwatch, and TradingView reported beforehand on Cresco Labs, Inc. (CRLBF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Cresco Labs, Inc. is one of the largest vertically integrated multi-state cannabis operators in the United States. It employs a consumer-packaged goods (CPG) approach to cannabis. The design of its family of brands is to meet the needs of all consumer segments. The Company’s products are sold in greater than 700 dispensaries throughout the nation. Cresco has 22 owned dispensaries. Cresco Labs is based in Chicago, Illinois. The Company lists on the OTC Markets Group’s OTCQX.

Cresco Labs’ brands include some of the most recognized and trusted national brands including Cresco, Remedi and Mindy’s, a line of edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside is Cresco’s national dispensary brand. Sunnyside is a wellness-centered retailer designed to build trust, education, as well as convenience for existing and new cannabis consumers.

Cresco Labs is a vertically integrated cannabis company. It controls its cultivation, manufacturing, extraction and packaging practices. The Company is involved at every point in the seed-to-sales process. Its facilities are powered by world-class agronomists, manufacturing experts and state-of-the-art agricultural equipment. Cresco packages, ships, and distributes its products across the nation, including locations owned and operated by its team.

Cresco Labs announced this past August that it received regulatory approval for its acquisition of 100 percent of the membership interests of Gloucester Street Capital, LLC, the parent entity of Valley Agriceuticals, LLC (Valley Ag) via a merger between Gloucester and an indirect subsidiary of Cresco Labs. Valley Ag holds one of the 10 vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health. Each license gives the operator the right to operate one cultivation facility and four dispensaries in New York. Recently, Valley Ag’s license was renewed for a two-year period.

Last month, Cresco Labs announced that it received Early Approval Adult-Use Dispensing Organization Licenses for all five of its existing Illinois medical cannabis dispensaries. The Company received approval for adult-use cultivation on September 30, 2019. This makes it the only company approved for both adult-use cultivation and adult-use dispensary operations in the State.

At present, Cresco Labs has five medical dispensaries in Illinois. These include Phoenix Botanical; MedMar Lakeview; MedMar Rockford; PDI Medical; and FloraMedex. Each of these dispensaries has received approval for adult-use sales. As an existing medical cannabis dispensary operator, Cresco Labs will receive an additional adult-use license for each of its current medical dispensaries that will bring the Company’s total adult-use footprint to 10 total retail dispensary locations.

Cresco Labs, Inc. (CRLBF), closed Monday's trading session at $5.719, off by 5.4711%, on 269,997 volume with 783 trades. The average volume for the last 3 months is 674,663 and the stock's 52-week low/high is $4.18588018/$14.3900003.

chart

Journey Energy, Inc. (JRNGF)

TipRanks, OTC Markets, Letstock.net, Trade Ideas, Capital Cube, Market Seat, Morningstar, PR Newswire, Stockwatch, Dividend Investor, MarketBeat, GuruFocus, Dividend.com, Tech Know Bits, Stockhouse, Nasdaq, Barchart, Wallet Investor, Market Screener, and TradingView reported previously on Journey Energy, Inc. (JRNGF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Journey Energy, Inc. engages in the exploration, development, and production of crude oil and natural gas in the Province of Alberta. Its emphasis is on oil-weighted operations in western Canada. The company previously went by the name Sword Energy, Inc. It changed its name to Journey Energy, Inc. in July of 2012. OTCQX-listed, Journey Energy is headquartered in Calgary, Alberta.

In July 2012, Journey Energy was created out of Sword Energy Inc. From November 2012 to December 2013 it acquired Herronton and 10 additional minor acquisitions. Journey Energy has grown from 4,000 BOE/d at (47 percent liquids) to 8,500 BOE/d (49 percent liquids) via organic growth and accretive acquisitions over two years.

Journey Energy’s expertise in horizontal, multi-frac drilling and secondary recovery methods permits the Company to profitably acquire and develop large oil-in-place reservoirs fairways. In the Central Region it has (4,800 boe/d; approximately 56 percent oil and NGLs) - Gilby-Duvernay, Crystal, Cherhill.

In the South Region the Company has (5,200 boe/d; roughly 38 percent oil and NGLs) - Matziwin, Skiff, Herronton. In the Resource Fairway it has shallow, low-risk development drilling in conventional oil pools.

The Company’s strategy is to increase its production base by drilling on its existing core lands, implementing waterflood projects, and by executing on accretive acquisitions. Journey Energy looks to optimize its legacy oil pools on existing lands via the application of best practices in horizontal drilling and, where feasible, with water floods. Furthermore, the Company is in the early phases of advancing development of an unconventional shale resource play in the oil window of the Duvernay, in the western shale basin of its central core area.

Today, OTC Markets Group, Inc. (OTCM), operator of financial markets for 10,000 U.S. and international securities, announced Journey Energy, Inc. (TSX: JOY; OTCQX: JRNGF) has qualified to trade on the OTCQX® Best Market.

Mr. Alex Verge, President and Chief Executive Officer of Journey Energy, said, "On behalf of Journey Energy Inc. we are very happy to be joining the OTCQX Market. We are excited to be able to provide more liquidity for our existing and new U.S. shareholders. We look forward to OTCQX facilitating the trading of our shares."

Journey Energy, Inc. (JRNGF), closed Monday's trading session at $1.54816, up 1.1869%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 1,404 and the stock's 52-week low/high is $1.39999997/$2.25427007.

chart

Kraig Biocraft Laboratories, Inc. (KBLB)

Stock Pulse, Investor Village, TipRanks, Simply Wall St, Infront Analytics, Discovery Stocks, Wallet Investor, Super Stock Screener, InvestorsHub, Insider Financial, Emerging Growth, Stockhouse, and Trading View reported beforehand on Kraig Biocraft Laboratories, Inc. (KBLB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kraig Biocraft Laboratories, Inc. is the foremost developer of genetically engineered spider silk based fibers. The Company has attained a series of scientific breakthroughs in the area of spider silk technology with implications for the international textile industry. Its genetic engineering research has succeeded in developing what many consider to be the holy grail of material science – a practical and cost-effective technology for producing recombinant spider silk based fibers on an industrial scale. OTCQB-listed, Kraig Biocraft Laboratories is based in Ann Arbor, Michigan.

The Company obtained at its inception, proprietary genetic engineering technology to unlock the mystery of producing spider silk. In early 2006, it obtained certain exclusive rights from the University of Wyoming to use the spider silk gene sequences in its field of use. Kraig Biocraft Laboratories is currently ramping up production of its Monster Silk™ and Dragon Silk™ for commercialization. It is also continuing to develop new and recombinant spider silk fibers.

Spider silk holds the potential of a lifesaving ballistic resistant material - lighter, thinner, flexible and hardier than steel material. It is among the strongest fibers produced in nature. Some spider species can produce up to seven different types of silk depending upon the spider’s specific need at that time.

Kraig Biocraft Laboratories has created the next generation of recombinant spider silk using the Company’s new design, gene editing, and incorporation approaches. It designed this approach to customize mechanical properties for specific commercial markets. The Company has demonstrated the ability to more speedily, accurately, and efficiently produce new transgenics.

Today, Kraig Biocraft Laboratories announced that its operations team at its Vietnamese subsidiary, Prodigy Textiles, completed rearing the Company’s initial batch of production silkworms. Kraig Biocraft’s specialized spider silk silkworms were hatched over a 7 day period starting on October 8, 2019 while Mr. Jon Rice, the Company’s Chief Operating Officer, was in Vietnam. The silkworms started spinning cocoons on October 27th and finished on November 2nd.

Mr. Rice said, “The Prodigy Textiles production ramp up continues to demonstrate the efficacy of our manufacturing strategy. The success of this first wave of operations will serve as the blueprint for the successive expansion. Our direct, drop-in strategy is already proving its effectiveness to scale Dragonsilk 2.0. We believe this demonstration of rapid expansion will clear the path to fast-track our operations growth and quickly reach our targeted capacity.”

Kraig Biocraft Laboratories, Inc. (KBLB), closed Monday's trading session at $0.2064, up 7.3881%, on 2,346,929 volume with 211 trades. The average volume for the last 3 months is 2,329,834 and the stock's 52-week low/high is $0.038400001/$0.507000029.

chart

NervGen Pharma Corp. (NGENF)

OTC Markets, Nasdaq, Wallet Investor, InvestorX, Market Screener, Stock Target Advisor, Investor Ideas, Investors Hangout, Stockhouse, MarketWatch, BioSpace, TipRanks, Barchart, Trading View, and Dividend.com reported previously on NervGen Pharma Corp. (NGENF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

NervGen Pharma Corp. is a regenerative medicine company listed on the OTC Markets Group’s OTCQX. Its commitment is to creating cutting-edge solutions for the treatment of nerve damage. This includes spinal cord and peripheral nerve injury. The Company’s lead compound is NVG-291. Incorporated in 2017, NervGen Pharma has its corporate headquarters in Vancouver, British Columbia.

NervGen’s core technology targets protein tyrosine phosphatase sigma (PTPσ). This is a neural receptor that impedes nerve regeneration. Inhibition of the PTPσ receptor has been shown to promote regeneration of damaged nerves and improvement of nerve function in animal models for diverse medical conditions. Research has been conducted on other applications of PTPs. This includes multiple sclerosis (MS), stroke, cardiac arrhythmia, and Alzheimer’s disease.

Furthermore, NervGen Pharma continues to research secondary applications. These include MS, acute myocardial infarction induced arrhythmia (AMI, commonly known as a heart attack), stroke and other neurodegenerative diseases.

NervGen Pharma’s plan is to begin a Phase 1 human clinical trial for its lead compound, NVG-291, in early 2020 under an Investigational New Drug application with the US Food and Drug Administration (FDA). The Company is advancing NVG-291 for the treatment of spinal cord injury as it believes this indication is a significant opportunity due to the present lack of non-surgical solutions in the market, the major impact on quality of life, and the high cost burden to the healthcare system.

NervGen’s belief is that NVG-291 as a therapy could alleviate or improve upon the symptoms and conditions associated with spinal cord injury. Additionally, it believes that NVG-291 as a therapy could empower these patients to live more active and productive lives.

This past September, NervGen Pharma announced the clinical development strategy for its compound, NVG-291, in two lead indications: spinal cord injury and multiple sclerosis. The Phase 1 safety and pharmacokinetic study in healthy subjects presently remains on course to start in Q1 of 2020 as originally scheduled. A cohort of spinal cord injury patients, an expansion of NervGen's Phase 1 trial, is scheduled to begin in the second half of 2020. A Phase 2 MS trial is scheduled to begin in Q1 of 2021.

Last week, NervGen Pharma announced a research initiative to advance its proprietary therapeutic technology platform, now in development for spinal cord injury and MS, to produce new treatments for Alzheimer's disease (AD).

Mr. Bill Radvak, NervGen Pharma's Executive Chairman, said, "NervGen's platform technology provides an innovative approach to treating Alzheimer's disease and has received positive affirmation from several Alzheimer's disease key opinion leaders. The essence of our technology is that it unlocks a damaged nervous system's natural ability to repair itself and this could translate to helping people suffering from Alzheimer's disease."

NervGen Pharma Corp. (NGENF), closed Monday's trading session at $1.26, up 0.80%, on 34,635 volume with 23 trades. The average volume for the last 3 months is 14,174 and the stock's 52-week low/high is $0.648800015/$1.72000002.

chart

Veritas Farms, Inc. (VFRM)

Alpha Stock News, Teletrader, Trader Social Network, Market Wire News, Biz Journals, Stock Target Advisor, Street Insider, GlobeNewswire, OTC.watch, Simply Wall St, Stockwatch, Investors Hangout, GuruFocus, Trading View, and Stockhouse reported previously on Veritas Farms, Inc. (VFRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Veritas Farms, Inc. centers on the production of full spectrum hemp extracts with naturally occurring cannabinoids. At present, the Company operates a 140-acre farm and production facilities in Pueblo, Colorado. It is registered with the Colorado Department of Agriculture to grow industrial hemp. All Veritas Farms™ brand products are third-party laboratory tested for strength and purity. A vertically-integrated agribusiness and OTCQB-listed, Veritas Farms is headquartered in Fort Lauderdale, Florida.

The Company’s dedication is to sustainable farming methods. Furthermore, Veritas has developed its own fertilizer that helps balance out the local ecosystem. Veritas Farms employs drip irrigation. This ensures that every plant gets the proper hydration and that Veritas conserves the Rocky Mountain water it uses. The Company does not grow from seeds; it always cultivates from mother plants. In addition, using clones enables Veritas Farms to maintain genetic stability.

Veritas markets and sells products under its Veritas Farms™ brand. Moreover, the Company manufactures private label products for a number of top distributors and retailers. Veritas Farms™ brand full spectrum hemp oil products include vegan capsules, tinctures, formulations for sublingual applications and infused edibles, lotions, salves, and oral syringes in an array of size formats and flavors. Veritas produces the highest quality, full spectrum CBD (cannabidiol) products from its sustainable farm in Pueblo, Colorado.

In October, Veritas Farms announced that it has expanded upon important areas of its product portfolio through launching new tinctures and topicals. The larger tincture is 3.38oz (100 mL’s). It contains a 1000mg concentration of full spectrum hemp oil combined with organic coconut derived MCT oil. The 3.38oz product offers 100 servings versus the 30 provided by the smaller contemporary tinctures. Veritas’ new massage oil is made in a glass 3.38oz bottle with a 500mg concentration of full spectrum hemp oil. It is blended with organic jojoba oil.

In addition, in October, Veritas Farms announced that it released a full-spectrum hemp infused sports cream in a 2 ounce convenient squeeze tube. Veritas Farms’ Chief Executive Officer and Co-founder, Mr. Alexander Salgado, said, “By focusing on expanding into the lucrative athletics niche, Veritas Farms is continuing to prove its credentials as an innovator in the full-spectrum-hemp field. Athletes require fast-acting and effective products in order to reach their maximum potential and our new Sports Cream provides just that.”

Veritas Farms, Inc. (VFRM), closed Monday's trading session at $1.60, even for the day, on 8,288 volume with 28 trades. The average volume for the last 3 months is 54,370 and the stock's 52-week low/high is $1.00/$9.15999984.

chart

WeedMD, Inc. (WDDMF)

Marijuana Stock Review, Profit Confidential, The Cannabis Investor, Investor Ideas, New Cannabis Ventures, Financial Buzz, Daily Marijuana Observer, Stock Day Media, OTC Markets, CannabisMarketCap, Pot Stock News, Micro Small Cap, Financial Insiders, Micro Small Cap, Midas Letter, Stockwatch, and Morningstar reported earlier on WeedMD, Inc. (WDDMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

WeedMD, Inc. is a federally-licensed producer and distributor of medical-grade cannabis. The Company is the publicly-traded parent company of WeedMD Rx, Inc., which is a federally-licensed producer and distributor of cannabis products for the medical and adult-use markets. WeedMD has a multi-channeled distribution strategy. This includes selling directly to medical patients, strategic relationships across the seniors’ market, and supply agreements with Shoppers Drug Mart and also six provincial distribution agencies. WeedMD has its head office in Aylmer, Ontario. The Company’s shares trade on the OTC Markets Group’s OTCQX.

WeedMD owns and operates two facilities. One is a 26,000 sq. ft. facility in Aylmer, Ontario. The other is a 158-acre state-of-the-art greenhouse and outdoor facility in Strathroy, Ontario. At present, the Company has 136,000 square feet of licensed indoor and greenhouse production space across its facilities. The Aylmer facility currently produces premium indoor flower.

WeedMD recently announced the launch of Color™ Cannabis. Color Cannabis was developed specifically for a diverse adult-use market that reflects the range in tastes and preferences of contemporary cannabis consumers. Color Cannabis products include an assortment of strains, in many formats, developed with premier quality cannabis. Color Cannabis is a first-class brand exclusively available to distributors and select retailers across Canada.

Along with premium dried flower, Color Cannabis will launch new product formats including pre-rolls, oils, and gel capsules with further consumption formats in development. Color will offer up to 10 inventive strains from WeedMD’s proprietary genetics collection. This collection includes a number of signature strains - Pedro’s Sweet Sativa, Ghost Train Haze, White Shark, ACDC, Ultra Sour and Mango Haze.

WeedMD has launched CX Industries, Inc., a wholly-owned subsidiary. CX Industries will specialize in extraction, toll processing and third-party product formulation from WeedMD’s fully-licensed Aylmer, Ontario facility. CX Industries will have the capacity to process more than 200,000 kgs of biomass at its peak production next year.

This past August, WeedMD announced that 40 of its medical cannabis strains were included in the completion of the first phase of TruTrace Technologies’ (previously BLOCKStrain Technology Corp.) medical cannabis verification pilot project with Shoppers Drug Mart. Phase 2 of the Pilot Project is targeted for completion late this month.

Built on TruTrace Technologies’ proprietary StrainSecure™ system that centers on cannabis product testing and verification to confirm origin, authenticity and quality, WeedMD is the first and only licensed producer to have 40 strains registered in the program. The technology helps in the protection of WeedMD’s innovative strains. It also assists its customers, including Shoppers Drug Mart, with strain and product authenticity.

In October, WeedMD announced it secured a Health Canada licence amendment approval for its purpose-built processing facility in Strathroy, Ontario. The stand-alone, 50,000 sq. ft. custom-built structure, situated on the Company’s 158-acre Strathroy property, will dry, process and cure all remaining outdoor-cultivated cannabis this calendar year and is built to process and store greater than 40 tons of dried cannabis biomass.

WeedMD, Inc. (WDDMF), closed Monday's trading session at $0.86, off by 0.543541%, on 38,739 volume with 59 trades. The average volume for the last 3 months is 73,835 and the stock's 52-week low/high is $0.728299975/$1.67499995.

chart

RedHawk Holdings Corp. (SNDD)

TopPennyStockMovers, Real Pennies, Greenbackers, Fast Money Alerts, Mad Money Picks, The Observer, Innovative Marketing, Penny Stock General, Stock Shock and Awe, PennyStocks24, and Hot Stock Profits reported earlier on RedHawk Holdings Corp. (SNDD), and we also report on the Company, here at the QualityStocks Daily Newsletter.

RedHawk Holdings Corp. is a diversified holding company listed on the OTC Markets. The Company, via its subsidiaries, engages in the sales and distribution of medical devices, sales of branded generic pharmaceutical drugs, commercial real estate investment and leasing, sales of point of entry full-body security systems, and specialized financial services. RedHawk Holdings was formerly Independence Energy Corp. RedHawk’s subsidiaries are RedHawk Medical, EcoGen Europe, RedHawk Energy Corp., and RedHawk Land & Hospitality. RedHawk Holdings is based in Louisiana.

RedHawk Energy holds the exclusive U.S. manufacturing and distribution rights for the Centri Controlled Entry System. This System is a unique, closed cabinet, nominal dose transmission full body x-ray scanner.

Through its RedHawk Medical Products business unit, RedHawk Holdings sells WoundClot Surgical - Advanced Bleeding Control; the Sharps and Needle Destruction Device (SANDD™); the Carotid Artery Digital Non-Contact Thermometer, and Zonis®.

RedHawk Medical Products UK Limited is a specialist medical device company. It delivers innovative product solutions to healthcare markets in the United Kingdom (UK), Europe and the Middle East.

EcoGen Europe’s dedication is to healthcare and the NHS. Its commitment is to securing savings across the drug budget in primary care. This is while providing innovation to drive patient care in the acute setting. Last month, RedHawk Holdings announced that it recently completed its financial and legal due diligence and upon execution of final agreements, it will increase its ownership interest in EcoGen Europe to 75 percent.

RedHawk’s financial services revenue is from brokerage services earned in association with debt placement services and investments in oil and gas exploration and production. The Company’s real estate leasing revenues come from varied commercial properties under long-term lease. Moreover, its real estate investment unit holds limited liability company interest in different commercial restoration projects in Hawaii.

EcoGen Europe has signed an exclusive agreement to license and supply a new non-patent infringing generic spray formulation of Sildenafil Citrate in the UK. EcoGen will market the new spray under the brand name Azulvig. EcoGen expects to start marketing Azulvig after receipt of final UK regulatory approval.

RedHawk Holdings has acquired a stake in Tigress Energy Partners. RedHawk agreed to acquire up to a 25 percent interest in Marlin USA Energy Partners, LLC, the minority owner of Tigress Energy Partners, LLC (TEP). The majority ownership of TEP is held by Tigress Holdings, LLC, a limited liability company majority-owned by Cynthia DiBartolo, Chief Executive Officer of Tigress Financial Partners LLC (TFP).

RedHawk Holdings has also completed the re-engineering of its Sharps and Needle Destruction Device (SANDD). It received pre-market clearance from the U.S. Food and Drug Administration (FDA) for the sale of SANDD in the U.S. RedHawk Medical Products acquired the tangible and intangible property rights to SANDD (formerly known as the Disintegrator™ Insulin Needle Destruction Unit) in December 2015.

Recently, RedHawk Holdings announced that its wholly-owned real estate subsidiary, RedHawk Land & Hospitality LLC, entered into new agreements for the lease of its two commercial properties in Lafayette, Louisiana. The Company said it entered into a new triple-net lease agreement with the Louisiana 3rd Circuit Court of Appeal to renew and extend the present lease term to December 31, 2022. The new lease agreement was effective August 1, 2017 and included certain rate increases.

RedHawk Holdings Corp. (SNDD), closed Monday's trading session at $0.0116, off by 7.20%, on 2,052,527 volume with 54 trades. The average volume for the last 3 months is 8,356,976 and the stock's 52-week low/high is $0.000799999/$0.017899999.

chart

Northsight Capital, Inc. (NCAP)

Awesome Penny Stocks, OTC Markets, InvestorsHub, GuruFocus, Insider Monkey, Stockopedia, Equity Clock, Marketwired, The Street, Equities, MarketWatch, Barchart, WhaleWisdom, Stockhouse, Simply Wall St, and Uptick Newswire reported previously on Northsight Capital, Inc. (NCAP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Northsight Capital, Inc. consists of a portfolio of online Cannabis-related websites that are undergoing development and operated by the Company. These sites incorporate numerous facets of the Cannabis industry. The Company is transitioning into two sectors. One is the Bitcoin ATM service industry. The other is its modern cannabis advertising and media platform. Northsight Capital is headquartered in Scottsdale, Arizona.

Northsight Capital does not sell or distribute any cannabis products. The Company is looking to acquire digital or publishing companies in the space. It has its 420Careers.com. This is a leading job site in the Cannabis space.

Northsight Capital also has its WeedDepot.com. This website provides consumers with a geo-targeted map directory of medical and recreational dispensaries, head shops, doctors, attorneys and more within the Cannabis industry. Weed Depot has a whole platform of content suited for every aspect of advertising and marketing to consumers from all businesses in the cannabis industry.

Northsight Capital earlier acquired Crush Mobile, LLC. Crush Mobile has developed a group of dating sites with a presence in the Latino, Israeli, and African American communities. Crush Mobile is a part of the Company’s growing media group. Crush Mobile has incorporated into its dating applications suite Northsight Capital's "Joint Lovers" dating app that centers on the Cannabis space.

Northsight Capital reached an agreement in principal in 2018 to be the exclusive distributor of CBD products for SeniorsCBD, a brand of Seniors for CBD. Northsight Capital and Seniors for CBD signed an agreement in principal to create the first CBD product line specifically for the seniors’ market. Seniors for CBD (www.SeniorsforCBD.com) is a leader in the industry for educating and informing seniors on the continuing research on medical marijuana and CBD through bringing current news each day to their followers.

This past December, Northsight Capital announced that it launched its new enhanced cannabis careers web site, www.420Careers.com. This site first launched in 2010. It is considered one of the foremost career sites in the cannabis arena. The site has been updated with many new more user-friendly features. These features make it easier for job seekers to post their resumes and also makes it easier for employers to access them. The 420Careers site has 2,000 to 3,000 visitors a day and roughly 1 million-page views per month.

Recently, Northsight Capital announced an agreement in principal to be the master distributer of 3 exclusive lines of CBD products. The initial orders will be shipped early next month. The lines include earlier announced SeniorsCBD, specializing in formulas specifically for seniors, LiquidMD, a CBD infused water, LiquidMD for pets, and Nature Grown CBD, Northsight’s generic brand.

The Company is expecting to receive the initial shipment of its CBD products on or about the first week of March. First distribution will be through Northsight's broad online media presence and also independent sales and distribution outlets.

Northsight Capital, Inc. (NCAP), closed Monday's trading session at $0.002, up 33.3333%, on 54,000 volume with 2 trades. The average volume for the last 3 months is 206,721 and the stock's 52-week low/high is $0.0015/$0.017.

chart

First Foods Group, Inc. (FIFG)

Stockwolf, Stockwatch, Wall-St, OTC Markets, Real Investment Advice, Investors Hangout, The Street, Market Screener, TradingView, Stockhouse, Penny Stock Hub, Euro Investor, YCharts, and MarketWatch reported on First Foods Group, Inc. (FIFG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

First Foods Group, Inc. has growing interests in the food and food service industry. The Company provides management services and financing options for new foodservice brands and menu concepts. Moreover, it is growing its new concepts through proprietary development and through mergers, acquisitions, and licensing arrangements. The Company formerly went by the name Litera Group, Inc. It changed its name to First Foods Group, Inc. in February 2017. First Foods Group has its head office in Las Vegas, Nevada.

First Foods Funding invests in short-term merchant cash advances that have been producing immediate high rates of return on capital. This Division continues to realize fast growth through the reinvestment of its profits while attracting substantial new funds from outside investors.

First Foods earlier signed cannabis business expert Mr. Robert Hunt, Esq. to identify opportunities in the legal cannabis industry where the Company’s management, expertise, and relationships could have considerable effect. Mr. Hunt is one of the distinguished consultants in the legalized marijuana industry. He has been instrumental in many of the best known and most successful cannabis businesses in operation today.

First Foods Group entered into a binding term sheet in April 2017 with globally renowned chocolatier and entrepreneur Mr. Oded Brenner. This is to fully develop Mr. Brenner’s new chocolate-based retail concept. The venture is jointly owned by First Foods Group and Mr. Brenner. Initial plans are to launch two flagship stores in New York, New York, and to immediately take advantage of numerous multi-unit global franchising opportunities.

Holy Cacao is marketing premium chocolate products created and packaged by Holy Cacao consultant, Mr. Oded Brenner, founder of "Max Brenner, Chocolate by the Bald Man," for the legal cannabis sector. Mr. Brenner has incorporated an exotic mix of champagnes, sherries, and select cannabis strains into his chocolate formulas.

First Foods Group registered its Holy Cacao® subsidiary with the State of Nevada on August 31, 2017. The Company stated that Holy Cacao will soon be licensed as a THC product in the legal marijuana states.

First Foods Group recently reported GAAP Revenue of $85,510 for the second fiscal quarter of 2018. This represents an increase of 42 percent over the GAAP Revenue of $60,295 reported for the first fiscal quarter of 2018. The Company’s financial results are supporting the expansion of its Holy Cacao subsidiary. This subsidiary is finalizing negotiations to produce high-end chocolate, which will be sold and distributed to the edibles market using First Foods’ trademarked brand and packaging.

First Foods Group, Inc. (FIFG), closed Monday's trading session at $0.34, up 17.2414%, on 14,207 volume with 14 trades. The average volume for the last 3 months is 206,721 and the stock's 52-week low/high is $0.050999999/$0.600000023.

chart

Ipsidy, Inc. (IDTY)

Investors Hangout, InvestorsHub, Investopedia, TradingView, Proactive Investors, Barchart, Stockwatch, Simply Wall St, OTC Markets, Stockhouse, 4-Traders, and Penny Stock Hub reported on Ipsidy, Inc. (IDTY), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Ipsidy, Inc. is a provider of secure, biometric identification, identity management and electronic transaction processing services. The Company’s identity transaction platform creates a trusted transaction, embedding authenticated identity and event details with a digital signature and using a participant's mobile device to approve everyday transactions.

Established in 2009, Ipsidy is based in Long Beach, New York. The Company lists on the OTC Markets OTCQX. It formerly went by the name ID Global Solutions Corporation. It changed its name to Ipsidy, Inc. in February 2017.

The Company’s platform is undergoing design to use biometric and multi-factor identity management solutions intended to support a wide spectrum of electronic transactions. Ipsidy’s belief is that it is critical that businesses and consumers know who is on the other side of an electronic transaction and have an audit trail, proving that the identity of the other party was properly authenticated.

Ipsidy’s identity transaction platform aims to help its customers more rapidly and effectively secure their citizens, employees, customers and associated physical and digital transactions, and promote a more secure, globally connected world. The Company’s identity platform enables mobile users to more easily authenticate their identity to a mobile phone or portable device of their choosing.

Ipsidy has two operating subsidiaries: MultiPay in Colombia, (www.multipay.com.co); and Cards Plus in South Africa, (www.cardsplus.co.za).

Recently, Ipsidy and Skypatrol LLC announced that they agreed to offer SkyGuru. SkyGuru combines Skypatrol's GPS technology with Ipsidy's Transact digital issuance platform and mobile biometrics to deliver integrated cost-control and expense management to trucking fleet operators and logistics companies across the Latin American market. Skypatrol is a provider of unique GPS-tracking and fleet-management software tools.

SkyGuru is powered by Ipsidy's Transact digital issuance platform providing the Ipsidy Mobile Wallet. This wallet is a virtual payment account for mobile devices. The fleet's drivers download the Ipsidy Mobile Wallet. They subsequently proceed to make their purchases of fuel or other services at participating gas station and other merchants, to which Skypatrol's systems can specifically route them.

Ipsidy, Inc. (IDTY), closed Monday's trading session at $0.0575, up 43.75%, on 169,400 volume with 16 trades. The average volume for the last 3 months is 117,968 and the stock's 52-week low/high is $0.024399999/$0.150000005.

chart

Force Protection Video Equipment Corp. (FPVD)

AimHighProfits, Promotion Stock Secrets,  and Insider Financial reported  earlier on Force Protection Video Equipment Corp. (FPVD), and today we highlight the Company, here at the QualityStocks Daily Newsletter. 

Force Protection Video Equipment Corp. (Force Protection)  sells high definition (HD) body camera systems and accessories for law enforcement. The Company offers its LE10 Law Enforcement Video Recorder product. Force Protection has its corporate headquarters in Cary, North Carolina.

The Company previously went by the name Enhancer-Your-Reputation.Com, Inc. It changed its name to Force Protection Video Equipment Corp. in March of 2015. 

Force Protection has incorporated a wholly-owned subsidiary, CobraXtreme HD Corp., a North Carolina Corporation. This subsidiary’s purpose is to sell HD videos sports cameras and accessories that are alike to those sold by GoPro. Furthermore, it will sell video goggles and sunglass cameras.

CobraXtremeHD also carries a complete line of aftermarket accessories for extreme sports cameras such as GoPro® and Garmin®. The design of CobraXtremeHD cameras are for use in extreme sports.

Force Protection has its LE50 HD Bodycam. The LE50 is a state-of-the-art designed body camera. It is strategically built around Ambarella chip sets (AMBA). Select important design features of the LE50 include industry leading record time (10 hours @1080,12 hours @720); 50 hours of standby time; 32GB of internal tamperproof storage; and white LED illumination.

Concerning the Company’s LE10 Law Enforcement Video Recorder product, it is a small bodyworn HD camera. It is half the size and half the price of most law enforcement cameras now on the market. The LE10 has manifold features. These include still picture ability 8MP, WIFI, 4x zoom,  and audio recording. The LE10 does not necessitate special software or costly storage contracts.

In addition, Force Protection released the LE100 and LE101 1080 HD in car video recording dashcam systems. The LE100 and 101 are state-of-the-art designed in-car dash camera systems. They are strategically built around Ambarella A7 chip sets (AMBA). 

The Company also has its camera system for Law Enforcement and Security Agencies. The design of the C1, Citadel camera system is to fight and deter graffiti, illegal dumping, and other property crimes. The self-contained system is solar powered.  The C1 Citadel requires no external power. All of Force Protection’s cameras and recording devices have FCC, IC and CE certification.

Recently, Force Protection announced the release of the RECON 1000 on the body camera. The RECON 1000 incorporates into its design the Ambarella A7 chip to ensure its optimal performance for law enforcement officers. The RECON 1000 is a robust IP67 camera. It is small, lightweight and full of standard features that cameras twice its size and price do not include.

Force Protection announced in May that it received patent pending status from the U.S. Patent and Trademark Office (USPTO) for its proprietary design titled: Shield Harness for Mounting a Camera. The newly designed product will permit law enforcement departments to use existing body worn cameras with their riot shields to collect evidence during protests and disturbances and also to document inmate extraction in prisons. The design will enable the cameras to be mounted securely and have an unobstructed view point of individuals for later identification and for training.

Force Protection Video Equipment Corp. (FPVD), closed Monday's trading session at $0.0002, up 100.00%, on 2,000,000 volume with 1 trade. The average volume for the last 3 months is 1,622,601 and the stock's 52-week low/high is $0.000096/$0.000199999.

chart

BNK Petroleum, Inc. (BNKPF)

Stockhouse, MarketWatch, OTC Markets, InvestorsHub, and Stock News Now reported on BNK Petroleum, Inc. (BNKPF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BNK Petroleum, Inc. is a global oil and gas exploration and production company headquartered in Camarillo, California. Its emphasis is on finding and exploiting large, mainly unconventional oil and gas resource plays. BNK owns and operates shale oil and gas properties in the U.S. Additionally, the Company is using its technical and operational expertise to identify and acquire additional unconventional projects. BNK Petroleum lists on the OTCQB.

BNK Petroleum has producing properties centered in the Ardmore basin of Oklahoma. The Company’s strategic aim is to maximize the value of its U.S. shale oil assets. This is while looking for more high-impact, large growth potential projects.

BNK is concentrating on the continued development and exploitation of its Tishomingo Shale oil property. The Company’s belief is that it can further increase its proven reserves through drilling step-out locations and in so doing convert possible and undocumented reserves to proved and probable reserves.

On October 13, 2017, BNK Petroleum announced that the Brock 9-2H well (100 percent working interest (WI)) averaged approximately 730 Barrels of oil equivalent per day (BOEPD); 625 barrels were oil, for the last 5 day (as of that date), while still producing back completion fluid. The production from the well, situated in the Company’s Tishomingo field, in the SCOOP region of Oklahoma, is presently greater than 600 BOEPD; 520 barrels are oil (87 percent) and appears to be stabilizing.

Mr. Wolf Regener, BNK Petroleum’s President and Chief Executive Officer, said in October, "The Brock 9-2H well was identified as a possible location on our year end 2016, NI 51-101 reserve report and is about a mile east of the closest proved location on that reserves report. This well demonstrates the excellent production that is achievable as we continue to expand our drilling in the field further east.”

Recently, BNK Petroleum announced its Q3 2017 results. Average production was 1,097 barrels of oil equivalent per day (BOEPD) for Q3 of 2017. This represents an increase of 7 percent versus Q3 2016 production of 1,024 BOEPD because of the production of one month from the Hartgraves 1-6H well.

Funds from continuing operations were $1.7 million for Q3 of 2017 versus $1.4 million in Q3 of 2016. Revenue, net of royalties was $2.9 million for Q3 of 2017 versus $2.3 million in Q3 of 2016 because of higher production.

Net loss was $1.3 million for Q3 of 2017 versus a net loss of $0.8 million in Q3 of 2016. The Q3 2017 net loss was attributable to a $1.3 million unrealized losses on commodity contracts.

BNK Petroleum, Inc. (BNKPF), closed Monday's trading session at $0.112, up 51.3514%, on 73,428 volume with 6 trades. The average volume for the last 3 months is 11,982 and the stock's 52-week low/high is $0.074/$0.285600006.

chart

Andrea Electronics Corp. (ANDR)

Stock Guru reported earlier on Andrea Electronics Corp. (ANDR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Andrea Electronics Corp. designs, develops, and manufactures audio technologies and equipment for enhancing applications necessitating high performance quality voice input. The Company is an innovator of digital audio input enhancement software, computer headsets, and array microphone technologies. In addition, it is an industry leading developer of product solutions that optimize the performance of voice user interfaces for different applications. Andrea Electronics is based in Bohemia, New York, it lists on the OTCQB.

Andrea’s patented Digital Super Directional Array (DSDA™), patented PureAudio™, and patented EchoStop™ far-field microphone technologies enhance a wide variety of audio products to eliminate background noise and ensure the optimum performance of voice applications. The Company’s products include Array Microphones, Active Noise Cancellation Microphone Headsets, USB Headsets, Headphones, Computer Microphones, USB Audio Adapters, Noise Reduction Software, and Echo Cancellation Software, which betters the performance and provides ease of use for applications.

These applications include Speech Recognition, Voice over the Internet (VoIP), Video conferencing, Game chat, and live digital audio recordings. Among the more recent advances from Andrea Electronics are SuperBeam Stereo Array Microphone headsets and the DA-250 digital microphone stand alone solution for original equipment manufacturers (OEMs).

Andrea Electronics has its Go Mic Connect, USB stereo array microphone with the Company’s audio enhancement software. This bundle is the most adaptive digital microphone on the market. The design of the Company’s latest filter libraries is for OEMs targeting new product platforms running Linux and Android operating systems. This is while using new strong mobile processors with DSP cores, including ARM.

The Andrea PC Audio Software (AudioCommander™) provides the latest Audio Commander and noise cancellation filters for use with all Andrea USB Devices. The install supports Windows.

Recently, Andrea Electronics announced that it is suing Apple, Inc. for patent infringement on audio processing technology found in the defendant's products. The hearing at the U.S. International Trade Commission in Washington, DC is set to commence today, August 21, 2017.

Mr. Douglas Andrea, Chief Executive Officer of Andrea Electronics, said, "We are a proud, third-generation family business whose products are showcased in the Henry Ford Museum and the Smithsonian National Museum, and we refuse to stand by and watch a legacy built over 80 years to be torn down by electronic giants with deep pockets and global influence. We are proud that Apple, like our already existing licensees, desires the use of our technology, but we request that they license it legally. If they refuse, we ask that the ITC stop them from selling products that contain our patented technology."

Andrea Electronics Corp. (ANDR), closed Monday's trading session at $0.0342, up 29.0566%, on 6,000 volume with 2 trades. The average volume for the last 3 months is 35,235 and the stock's 52-week low/high is $0.026399999/$0.079999998.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, today announced that is has closed the acquisition of BeneYOU, LLC's assets with an effective date of November 1, 2019. According to the update, BeneYOU's flagship brand Jamberry has a core competency in social selling with an extensive line of nail products, Avisae focuses on gut health and M.Global delivers hydration products. To view the full press release, visit http://cnw.fm/0Wz5M

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed Monday's trading session at $4.48, up 1.5873%, on 35,913 volume with 247 trades. The average volume for the last 3 months is 35,235 and the stock's 52-week low/high is $3.76999998/$9.77999973.

Recent News

chart

Green Hygienics Holdings Inc. (OTC: GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings Inc. (OTC: GRYN) was featured today in the 420 with CNW by CannabisNewsWire. On Wednesday, Wisconsin lawmakers filed legislation for decriminalizing marijuana possession. The two democratic representatives together with Lt. Governor Mandela Barnes, who supported the change in policy, held a press conference on the same day to announce the legislation.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium hemp cultivation and branding enterprise focused on the cultivation and processing of industrial hemp for the purpose of extracting cannabidiol (CBD). With more than 25 years of experience in agricultural science and innovation, Green Hygienics aims to become one of the largest providers of industrial hemp-derived CBD products on the planet.

Green Hygienics’ business model includes generating revenues from the sale of hemp and premium-grade CBD products, creating trusted global consumer brands, developing valuable intellectual property (IP) and growing rapidly through strategic acquisitions. With direct regard to acquisitions, the company acts as a business accelerator and a vertical integrator supporting rapid growth and development of companies with extraordinary potential.

Innovation – the Future of Commercial Cultivation

The greatest challenge of the cannabis industry is determining how to deliver a safe and premium-quality product on a consistent basis; antiquated production methods are riddled with recalls and are unsafe from a cultivation production standpoint. Green Hygienics’ solution is to employ scientific methodology combined with sustainable farm practices to achieve optimal soil refinement. The company’s objectives are to produce higher yields and a superior product on a consistent basis to always remain compliant through diligent testing. A secure, premium-quality supply chain is the foundation for the company’s operations.

Green Hygienics’ cultivation approach is based on scientific measurements and data analysis, which transform the cultivation environment into a laboratory environment to deliver superior product.

State-of-the-Art Processing

Processing hemp to produce the finest-quality CBD is a complex, multistage process that should be performed with adherence to the highest standards. Once harvested, the hemp must be carefully handled, dried and stored to prepare it for CBD extraction. Each and every step must be given full care and attention. Green Hygienics’ ambition is to create state-of-the-art infrastructure, employ the latest large-scale processing technologies and adhere to strict quality management systems.

The company strives to constantly develop innovations in industrial hemp for CBD cultivation and to create solutions that lower costs, deliver higher yields and address the challenges of large-scale production.

Brand Development, Marketing and Direct Sales

One of the core drivers of the Green Hygienics business model is to develop or acquire unique brands with global distribution potential. The company sees the market becoming increasingly competitive, and establishing Green Hygienics’ own distinct, trusted brands will be important. By controlling its own supply chain, the company can also leverage strategic advantages in the marketplace, such as the ability to deliver a “best in class” product on a consistent basis. Successful branding is demonstrated by a positive response to a company’s customer service, reputation and products, and Green Hygienics Holdings is acutely aware of the value in this.

Ahead of the Curve

The clear competitive advantage Green Hygienics holds over industry peers is cultivating premium product within the upper-scale product category more efficiently than anyone else in the industry. Currently, the average-size hemp farm in North America is 9 acres. Green Hygienics addresses the challenge of scalability through its farming methodology.

The company’s objective is to produce a higher quality of product at a lower cost and to deliver the finest-quality product to consumers without exception.

In today’s market, inefficient companies and those that produce an inferior product will become vulnerable or disappear, adding considerable value to companies like Green Hygienics that efficiently innovate and operate. The premium cannabis market will continue to achieve higher pricing, and the demand will stabilize. At the end of the day, successful branding backed by superior product will cause companies like Green Hygienics to rise above the competition.

Outlook

Companies within the cannabis sector, states and lawmakers are still figuring out how legislation, consumer demand and innovations will shape the industry. As a safeguard and for long-term resilience, Green Hygienics is preparing for the next plateau with proprietary cultivation and processing systems and tightly controlled growth environments that enable containment of production costs, delivery of higher yields and production of a premium product. These margins will provide the company with a strategic advantage within an increasingly competitive marketplace.

Green Hygienics is constantly studying the market dynamics in North America and abroad and anticipates that both the domestic and international markets will appreciate and be willing to pay a premium to those companies that can deliver best-in-class products.

In line with this expectation, the company’s additional objectives are to secure investment, enhance its balance sheet and increase its value through profitable operations as well as through acquiring and owning the real estate or land it builds upon. Over the long term, this will help Green Hygienics grow in value, provide leverage for rapid expansion and offer security for investors. The company will be positioned to capitalize on any opportunity within the industry or to acquire distressed assets, which is part of its growth strategy.

Green Hygienics plans to establish lead brands starting in the California market, to secure trademarks, and to develop and secure intellectual property assets with regard to cultivation and processing.

Green Hygienics Holdings Inc. (GRYN), closed Monday's trading session at $2.29, up 4.5662%, on 14,070 volume with 15 trades. The average volume for the last 3 months is 51,271 and the stock's 52-week low/high is $0.100100003/$2.48000001.

Recent News

chart

OriginClear (OTC: OCLND)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLND).

OriginClear’s (OTC: OCLN) CEO Riggs Eckelberry was featured in a recent article by Jeremy Ryan Slate of Grit Daily(TM) discussing Eckelberry’s plans to drive the disruption of Big Water, a trillion-dollar industry that has fallen behind the times and is affecting the health of millions. To view the full press release, visit http://nnw.fm/H73wN

OriginClear (OTC: OCLND) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLND), closed Monday's trading session at $1.05, up 75.00%, on 162,711 volume with 216 trades. The average volume for the last 3 months is 83,083 and the stock's 52-week low/high is $0.100000001/$9.60000038.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today issued a letter to its shareholders from its CEO Jimmy Chan. In the letter, Chan discusses completion of the company’s landmark deal to acquire BZRTH, LLC, which is expected to position Sugarmade as one of the largest publicly traded companies in the overall hydroponics space and drive EBITDA profitability, net-positive cash flows and top-line sales of $37 million on a forward basis. To view the full press release, visit http://cnw.fm/7kogM

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Monday's trading session at $0.018, up 5.8824%, on 11,205,550 volume with 333 trades. The average volume for the last 3 months is 54,303,720 and the stock's 52-week low/high is $0.00975/$0.125.

Recent News

chart

Neutra Corp. (OTCQB: NTRR)

The QualityStocks Daily Newsletter would like to spotlight Neutra Corp. (NTRR).

Early-stage research and development company Neutra Corp. (OTC: NTRR)today announced its payment of two convertible notes in recent months, thereby reducing the company’s short-term debt by $373,940 and putting it in a strong position as the year comes to a close. According to the update, repayment of the notes continues a string of success for Neutra over the past 10 months, including several important completed acquisitions, as well as one now pending. To view the full press release, visit http://cnw.fm/Ion1f

Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.

Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.

Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.

Acquisitions

  • VIVIS – Neutra continues to expand its market presence in the rapidly growing hemp-derived CBD market and recently acquired VIVIS, an emerging retail brand of hemp-based health and nutritional products. VIVIS’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With VIVIS as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
  • J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.

Partners

  • Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
  • ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.

Leadership

Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.

Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.

Neutra Corp. (OTCQB: NTRR), closed Monday's trading session at $0.0012, up 71.4286%, on 159,169,164 volume with 823 trades. The average volume for the last 3 months is 32,699,545 and the stock's 52-week low/high is $0.0006/$0.069799996.

Recent News

chart

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in a publication from CBDWire, examining how, for years, the residents of Iowa have lamented over the exclusion of PTSD from the state’s heavily restricted medical cannabis program. Medical cannabis is a potent natural medicine that can help manage a host of medical conditions. Luckily for people with PTSD, medical marijuana has been found to be effective at reducing the symptoms of the condition.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $3.26, off by 4.3988%, on 1,274,699 volume with 4,698 trades. The average volume for the last 3 months is 1,830,226 and the stock's 52-week low/high is $2.71000003/$8.43999958.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF), a leading cannabis branded products company in the U.S., today announced the addition of Brit + Co President Jill Braff to its board of directors. According to the update, Braff brings decades of experience in marketing and e-commerce through serving in various leadership roles for a number of well-known companies, including HSN, Ellen (DeGeneres) Digital Ventures, Ancestry.com, and, most recently, Brit + Co. Braff has received numerous awards and recognitions throughout her career, including being named one of the 40 Most Influential People Under 40 by Silicon Valley Business Journal and one of the Top Women in Digital by Cynopsis Media. To view the full press release, visit http://cnw.fm/lPl71

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Monday's trading session at $1.56, off by 8.2353%, on 33,962 volume with 85 trades. The average volume for the last 3 months is 46,832 and the stock's 52-week low/high is $1.43459999/$6.00810003.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The only certified-organic scaled producer in the industry, The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is committed to more than just cultivating premium organic cannabis. TGOD works to cultivate a way of life, ensuring that from seed, soil and beyond, every step of the company’s cultivating process is designed to make a difference. Also today, the company was highlighted in a publication from Motley Fool, examining how roughly one year ago, marijuana stocks could do little wrong. With Canada officially legalizing the sale of recreational marijuana and opening its doors to consumers on Oct. 17, 2018, the sky seemed to be the limit for pot stocks. But a lot can change in a year.Additionally, the company was featured in the 420 with CNW by CannabisNewsWire.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $0.8173, off by 4.5768%, on 1,026,509 volume with 701 trades. The average volume for the last 3 months is 1,422,752 and the stock's 52-week low/high is $0.685999989/$4.38000011.

Recent News

chart

Willow Biosciences Inc. (CSE: WLLW)

The QualityStocks Daily Newsletter would like to spotlight Willow Biosciences Inc. (CSE: WLLW).

Willow Biosciences Inc. (CSE: WLLW) was featured today in a publication from CBDWire, examining how, for years, the residents of Iowa have lamented over the exclusion of PTSD from the state’s heavily restricted medical cannabis program. Medical cannabis is a potent natural medicine that can help manage a host of medical conditions.

Willow Biosciences Inc. (CSE: WLLW) is a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates. The company’s cannabidiol (“CBD”) yeast-based biosynthesis program produces a high yield, ultrapure, low-cost and scalable manufacturing solution for pharmaceutical, food, beverage and personal care consumers of CBD.

The company is headquartered in Calgary, Alberta, Canada.

Biosynthesis Platform

Willow’s proprietary yeast-based lab strains produce CBD, tetrahydrocannabinol (“THC”), and cannabigerol (“CBG”), as well as certain minor and novel cannabinoids.

The company’s expertise in the esoteric field of biosynthesis and in delivering commercial fermentation pathways for the production of pharmaceutical-grade compounds grew from its origins in opiate research. Willow recently delivered a de novo biosynthesis pathway in yeast for thebaine, a key precursor API used as a feedstock in the manufacture of semi-synthetic opiates such as naloxone (used to reverse opioid overdose) and several common analgesics. Led by Chief Scientific Officer Dr. Peter Facchini, Willow’s research team discovered and patented numerous previously unknown genes coding for core catalytic pathway enzymes, as well as a number of additional non-pathway, yet commercially-essential, accessory genes.

Utilizing this proven synthetic biology platform, Willow’s research team has already begun producing cannabinoids at lab scale, using yeast as the host cell “factory.” This biosynthetic fermentation-based process is capable of producing pharmaceutical grade CBD in 10 days – far less time than traditional plant-based extraction methods.

Willow anticipates its technology can be scaled to produce hundreds of kilograms per batch of cannabinoid API at less than $1,000 per kilogram, thus costing approximately 60% less than current chemical synthesis methods and 90% less than conventional plant-based extraction methods.

World-Class Collaboration

Willow and Noramco Inc., the world’s largest producer of high-quality synthetic cannabinoid APIs and other controlled substance APIs for the pharmaceutical and healthcare industry, have an exclusive, worldwide Joint Development Agreement (“JDA”) to design a yeast-based biosynthesis platform for the production and distribution of a highly pure CBD isolate.

The mutually exclusive agreement calls for Willow to be responsible for optimizing yeast strains in a biosynthetic process to generate ultrapure CBD at high yield and substantially lower cost compared to current methods. Noramco will leverage its decades of experience in producing and delivering CBD and pharmaceutical APIs by being responsible for the scale-up, regulatory submission, marketing and distribution of products manufactured under the JDA.

Each company will invest comparable funds, will retain the intellectual property associated with their respective scopes of work and share equally in gross profits from sales of products manufactured under the JDA.

Market Opportunity

The agreement with Noramco (http://nnw.fm/Mz1vW) addresses the increasing demand for CBD-based APIs and other CBD-infused products by pharmaceutical, nutraceutical, consumer packaged goods, beverages and other industry sectors.

The U.S. market potential of cannabinoids is significant, with industry analysts projecting $50 billion in cannabinoid-based pharmaceutical sales and $16 billion in CBD consumer goods retail sales by 2025. As of June 2019, 34 U.S. states and the District of Columbia, Guam, Puerto Rico and U.S. Virgin Islands have legalized cannabis for medical use. Another 13 states and territories have approved recreational cannabis for adult use while other states are considering similar measures.

The cannabinoid API market continues to evolve with CBD and other cannabinoid-based treatment options currently in clinical trials for indications such as post-traumatic stress syndrome, epilepsy, Parkinson’s disease, chronic pain, schizophrenia, cancer treatments and other challenging unmet medical conditions.

Capitalization

Willow is fully funded after raising $29 million via private placement and $8 million in exercised warrants by Tuatara Capital Fund II, L.P. Proceeds of the funding will be used to enhance the existing laboratory space in Calgary and Vancouver, Canada, and in San Francisco, California. The company anticipates exiting 2020 with $15.8 million in cash.

Leadership

President and CEO Trevor Peters is an experienced executive who co-founded four startup companies in the past 15 years. He has raised over $1 billion in equity and debt financings at various stages of corporate development and has been integral to successful transactions totaling over $4 billion on sale. Mr. Peters previously was chief financial officer at Caracal Energy Inc., which sold to Glencore plc in 2014 for $1.8 billion.

Chief Financial Officer Travis Doupe has over 18 years of experience in financial leadership roles, principally in the international oil and gas industry, where he provided corporate strategic direction while overseeing all aspects of financial operations. Mr. Doupe is the treasurer and a member of the board of directors of the Canada Council for the Americas – Alberta and holds a CA-CPA designation and earned a bachelor’s degree in management from the University of Calgary.

Dr. Peter Facchini, Chief Scientific Officer, has been professor of plant biochemistry in the Department of Biological Sciences at the University of Calgary since 1995. He is recognized internationally as a leader in plant specialized metabolite biosynthesis. Dr. Facchini is the Canada Research Chair in Plant Metabolic Processes Biotechnology and has published more than 150 research papers and scholarly articles. Dr. Facchini received a PhD from the University of Toronto and conducted postdoctoral research at the University of Kentucky and Université de Montréal.

Dr. Joseph Tucker, Executive Chairman of the Board of Directors, holds more than 20 issued or pending patents and is a member of the Board of Directors of BioAlberta. He has extensive senior leadership experience in multiple public and private biotech companies. Dr. Tucker received a PhD in biochemistry and molecular biology from the University of Calgary.

Willow Biosciences Inc. (CSE: WLLW), closed Monday's trading session at $0.70, off by 6.67%, on 103,338 volume with 33 trades. The average volume for the last 3 months is 92,033 and the stock's 52-week low/high is $0.529999971/$5.25.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) was featured today in a publication from HempWireNews, examining how Jud Haward is a hemp farmer from Utah whose crop is now drying in his barn after harvesting. He has used the hanging method to dry his plants and the drying hemp is filling the air with a heavenly cannabis aroma. He is proud of the hemp yields from his 10-acres despite having sold only a part of the crop.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Monday's trading session at $0.5399, off by 7.3252%, on 98,353 volume with 93 trades. The average volume for the last 3 months is 172,809 and the stock's 52-week low/high is $0.399800002/$1.70000004.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that Joel Toguri has joined the company as its senior vice president ("SVP") of Commercial. According to the update, Toguri’s responsibilities in this role will include establishment and oversight of the company's provincial and retail sales strategy across all brands. To view the full press release, visit http://cnw.fm/ki7iM

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Monday's trading session at $0.5146, off by 4.7037%, on 349,261 volume with 322 trades. The average volume for the last 3 months is 965,914 and the stock's 52-week low/high is $0.479999989/$1.7888.

Recent News

chart

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA).

Marijuana Company of America (OTCQB: MCOA) was featured today in a publication from HempWireNews, examining how Utah has issued 220 industrial hemp licenses since the government legalized hemp production for industrial use. A hemp license was regarded as a golden ticket because of the popularity of cannabidiol, also known as CBD oil, which is an extract of hemp. CBD oil can be used for medicinal purposes, and it can also be used in other products such as CBD deodorant or CBD hamburgers.

Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.

Marijuana Company of America Inc. (MCOA), closed Monday's trading session at $0.17, off by 10.5263%, on 548,338 volume with 172 trades. The average volume for the last 3 months is 670,196 and the stock's 52-week low/high is $0.023/$2.10599994.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint’s (OTCQB: SING)subsidiary, Direct Solar of America, today announced its entry into a MOU with SchollyME. According to the update, the parties will collaborate on marketing Direct Solar through the high school programs that SchollyME is currently working with. To view the full press release, visit http://nnw.fm/jbT4Y

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.0112, off by 2.7778%, on 2,052,833 volume with 89 trades. The average volume for the last 3 months is 2,742,686 and the stock's 52-week low/high is $0.009999999/$0.028999999.

Recent News

chart

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

LiveWire Ergogenics Inc. (OTC: LVVV), a forward-thinking company involved in the acquisition, licensing and management of fully compliant turnkey facilities for the production of cannabis-based products and services in California, recognizes the importance of – and is committed to – doing business right in an industry rife with legal complexities. As the country’s attitude toward cannabis warms, LiveWire looks to lessons learned during the prohibition era to ensure company growth and success.

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Monday's trading session at $0.0058, off by 3.3333%, on 8,861,651 volume with 51 trades. The average volume for the last 3 months is 972,661 and the stock's 52-week low/high is $0.004199999/$0.0405.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.